* Accomplished, driven scientific leader and Pharma/Consumer Health Executive with 25 years experience in preclinical development, CIR/CIM, translational research, indications discovery, microbiome research and platform technologies including screening, computational biology and biomarker development* Executive Director, Center for Gut Microbiome and Nutrition Research and Associate Professor at Washington University in St Louis. Working with Jeff Gordon to translate discoveries from the lab’s preclinical research pipeline into clinically proven, mechanistically-defined microbiota-targeted therapeutics for treating the dual burden of obesity and undernutrition and their associated metabolic abnormalities- Recipient of Clinical Research Forum Top 10 Achievement Award- Icddr,b Award for contributions to malnutrition research- WHO - Invited expert- Associate Editor, Frontiers in Nutrition - Academic Editor, Nutrients- USDA study section member- 45 peer reviewed publications, 17 patents/patent applications* In depth knowledge of topical and oral drug discovery and early development across multiple therapeutic areas. Led large multi-disciplinary teams engaged in target identification through IND in dermatology, antibacterials, inflammation, cardiovascular diseases & neuroscience, contributing to the delivery of multiple candidates into clinical development. Edited the first book on drug repositioning * Experienced leader of dislocative external collaborations and strategic alliances, with a track record of fostering impactful academic/industry partnerships